517 related articles for article (PubMed ID: 32194864)
21. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
[TBL] [Abstract][Full Text] [Related]
22. Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C; Trafalis DT
Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic advances for glioblastoma multiforme: current status and future prospects.
Robins HI; Chang S; Butowski N; Mehta M
Curr Oncol Rep; 2007 Jan; 9(1):66-70. PubMed ID: 17164050
[TBL] [Abstract][Full Text] [Related]
24. A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy (Review).
Naser R; Dilabazian H; Bahr H; Barakat A; El-Sibai M
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36102321
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral beta interferon and systemic chemotherapy. Preliminary data in GBM patients.
Silvani A; Milanesi I; Munari L; Broggi G; Botturi M; Boiardi A
J Neurosurg Sci; 1990; 34(3-4):257-9. PubMed ID: 1965905
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment.
Sousa F; Moura RP; Moreira E; Martins C; Sarmento B
Adv Protein Chem Struct Biol; 2018; 112():61-80. PubMed ID: 29680243
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in targeted drug delivery for the treatment of glioblastoma.
Mao M; Wu Y; He Q
Nanoscale; 2024 May; 16(18):8689-8707. PubMed ID: 38606460
[TBL] [Abstract][Full Text] [Related]
28. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
29. Novel delivery strategies for glioblastoma.
Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.
Candolfi M; Kroeger KM; Muhammad AK; Yagiz K; Farrokhi C; Pechnick RN; Lowenstein PR; Castro MG
Curr Gene Ther; 2009 Oct; 9(5):409-21. PubMed ID: 19860655
[TBL] [Abstract][Full Text] [Related]
32. Spinal glioblastoma multiforme of the conus medullaris with holocordal and intracranial spread in a child: a case report and review of the literature.
Mori K; Imai S; Shimizu J; Taga T; Ishida M; Matsusue Y
Spine J; 2012 Jan; 12(1):e1-6. PubMed ID: 22197783
[TBL] [Abstract][Full Text] [Related]
33. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
34. Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.
Corso CD; Bindra RS
Semin Radiat Oncol; 2016 Oct; 26(4):281-98. PubMed ID: 27619250
[TBL] [Abstract][Full Text] [Related]
35. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
[TBL] [Abstract][Full Text] [Related]
36. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
37. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
Bambury RM; Morris PG
Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract][Full Text] [Related]
39. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
Curtin JF; King GD; Candolfi M; Greeno RB; Kroeger KM; Lowenstein PR; Castro MG
Curr Top Med Chem; 2005; 5(12):1151-70. PubMed ID: 16248789
[TBL] [Abstract][Full Text] [Related]
40. Emerging therapeutic targets and agents for glioblastoma migrating cells.
Di C; Mattox AK; Harward S; Adamson C
Anticancer Agents Med Chem; 2010 Sep; 10(7):543-55. PubMed ID: 20950259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
